Open
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

7 trades

Disclosure transactions for Tempest Therapeutics
Reporting person Filed Transaction Transaction value Source Actions
Frederick John W. Director Nov 2, 2026 20-day lag Award Oct 13, 2026 $0 Filed shares x price SEC Form 4 View filing
Smith Nancy Freda Director Oct 2, 2026 10-day lag Award Sep 22, 2026 $0 Filed shares x price SEC Form 4 View filing
Angel Matthew CEO And President Jun 23, 2026 91-day lag Buy Mar 24, 2026 Not reported Reported range SEC Form 4 View filing
Angel Matthew CEO And President Jun 23, 2026 91-day lag Buy Mar 24, 2026 $500K Filed shares x price SEC Form 4 View filing
Angel Matthew CEO And President Jun 23, 2026 91-day lag Buy Mar 24, 2026 Not reported Reported range SEC Form 4 View filing
Yee John D. Director Jun 17, 2026 13-day lag Award Jun 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Richey William Drake Director Jun 8, 2026 4-day lag Award Jun 4, 2026 $0 Filed shares x price SEC Form 4 View filing
Frederick John W. Director
Award
Calculated transaction value
$0 25,000 shares @ $0
Traded
Oct 13, 2026
Filed
Nov 2, 2026
Smith Nancy Freda Director
Award
Calculated transaction value
$0 25,000 shares @ $0
Traded
Sep 22, 2026
Filed
Oct 2, 2026
Angel Matthew CEO And President
Buy
Reported value range
Not reported 231,482 shares
Traded
Mar 24, 2026
Filed
Jun 23, 2026
Angel Matthew CEO And President
Buy
Calculated transaction value
$500K 231,482 shares @ $2.16
Traded
Mar 24, 2026
Filed
Jun 23, 2026
Angel Matthew CEO And President
Buy
Reported value range
Not reported 231,482 shares
Traded
Mar 24, 2026
Filed
Jun 23, 2026
Yee John D. Director
Award
Calculated transaction value
$0 25,000 shares @ $0
Traded
Jun 4, 2026
Filed
Jun 17, 2026
Richey William Drake Director
Award
Calculated transaction value
$0 25,000 shares @ $0
Traded
Jun 4, 2026
Filed
Jun 8, 2026